Professor Nicholas Economides provides perspective on the regulatory impact of the ruling in the AT&T and Time Warner merger
— March 16, 2018
Excerpt from The Washington Post -- "The antitrust debate is giving pause to business leaders nationwide, analysts say, particularly in the health-care sector, where a bevy of recent cross-industry deals could raise similar regulatory issues. CVS’s $69 billion acquisition of the health insurer Aetna, as well as Cigna’s $52 billion purchase of Express Scripts, could both be affected by the AT&T trial, analysts say. 'If the government wins this case, they would be concerned,' said Nicholas Economides, an economics professor at New York University’s Stern School of Business."